Company Name, Ticker, Industry, else..
STOCKS
HOME
Stock Profile
Company Fundamentals
Financial Results
ARTH's Officers & Directors
Company Descriptions
Charts & Quotes
News
Company Suppliers
Company Competitors
Company Markets Customers
Economic Indicators
INDUSTRIES
Revenue Growth by Industry
Net Income Growth by Industry
Net Margin by Industry
PE by Industry
Total Debt to Equity by Industry
Revenue per Employee by Industry
Return On Assets by Industry
Performance by Industry
Growth Rates by Industry
Profitability by Industry
Valuation by Industry
Financial Strength by Industry
ECONOMY
Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
U.S. International Trade
Factory orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
MARKETS
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
SCREENING
Stock Performance Screening
Profitability Screening
Valuation Screening
Dividend Screening
Financial Strength Screening
Efficiency Screening
Largest Companies
Mgmnt. Effectivness Screening
NEWS
Stock News
Economy News
GLOSSARY
Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
HELP
Company Profile
Arch Therapeutics Inc News
Arch Therapeutics Inc's Operating Margin
Arch Therapeutics Inc's Dividend Pay out
Arch Therapeutics Inc Business Description
Arch Therapeutics Inc Executive Officers
Economic Indicators
Fundamentals
Arch Therapeutics Inc Growth Rates
Arch Therapeutics Inc Profitability
Arch Therapeutics Inc Valuation
Arch Therapeutics Inc Management Effectiveness
Arch Therapeutics Inc Financial Strength
Arch Therapeutics Inc Efficiency
Arch Therapeutics Inc Dividend
Financials
Arch Therapeutics Inc Business Segments
Arch Therapeutics Inc Income Statement
Arch Therapeutics Inc Balance Sheets
Arch Therapeutics Inc Cash Flow Statement
Arch Therapeutics Inc Geographic Information
Suppliers
Arch Therapeutics Inc Suppliers Performance
ARTH Suppliers Stock Performance
ARTH Suppliers Growth Rates
ARTH Suppliers Data
ARTH Suppliers Efficiency
ARTH Suppliers Management Effectiveness
ARTH Suppliers Valuation
ARTH Suppliers by Companys' Segments
Competition
Competition by Companys' Segments
Arch Therapeutics Inc Market Share
Arch Therapeutics Inc Competition Performance
Arch Therapeutics Inc Competitors Results
ARTH Competitors Stock Performance
ARTH Competitors Growth Rates
ARTH Workforce Efficiency at the Competitors
ARTH Competitors Efficiency
ARTH Competitors Management Effectiveness
ARTH Competitors Valuation
Customers & Markets
Arch Therapeutics Inc Customers Demand
ARTH Customers Expenditure Growth Rates
ARTH Customers Performance
ARTH Customers Stock Performance
ARTH Customers Growth Rates
ARTH Workforce Efficiency at the Customers
ARTH Customers Efficiency
ARTH Customers Management Effectiveness
ARTH Customers Valuation
ARTH Customers by Companys' Segments
Charts & Quotes
Arch Therapeutics Inc Comparison Charts
ARTH OHLC Charts
ARTH's Tehnical Upper Indicators
ARTH's Tehnical Lower Indicators
ARTH's Weekly Charts
ARTH's Monthly Charts
Arch Therapeutics Inc's Profile
Company Charts and Quotes
Arch Therapeutics Inc News
Arch Therapeutics Inc's Executive Officers
Arch Therapeutics Inc's Income Statement
Arch Therapeutics Inc's Balance Sheets
Arch Therapeutics Inc's Cash Flow Statement
Arch Therapeutics Inc's Profitability
Arch Therapeutics Inc's Financials
ARTH's Company\'s Dividend
Arch Therapeutics Inc's Suppliers
Arch Therapeutics Inc's Competitors
Arch Therapeutics Inc's Markets & Customers
Arch Therapeutics Inc's Market Share
ARTH's Suppliers Efficiency
ARTH's Competitors Management Effectiveness
ARTH's Charts Average True Range (ATR)
Arch Therapeutics Inc's Customers Expenditure Growth Rates
Economic Indicators
Growth Rates by Industry
Financial Strength Screening
Markets at a Glance
Stocks
Cryptocurrencies
Sectors & Industries
Commodities
Foreign Exchange
Stocks in 2023
U.S. International Trade
News
Economy News
Stock News
Financial Terms
At a Glance
Growth Rates
• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Arch Therapeutics Inc
(
ARTH
)
Other Ticker:
Sector
•
Healthcare
Industry
•
Medical Equipment & Supplies
Industry
•
Medical Equipment & Supplies
Sector
•
Healthcare
Arch Therapeutics Inc 's Yearly Income from Continued Operations Growth 5 Years
Select the Comparisons :
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Select the Ratio:
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
None ▼
Growth Rates
Profitability
Valuation Comparisons
Management Effectiveness
Financial Strength
Efficiency
Dividend Comparisons
Annual Income from Cont. Operations Annual Growth Rates Y/Y▼
Revenue Y/Y
Op. Income Y/Y
Income from Cont. Operations Y/Y
Net Income Y/Y
Effective Tax Rate
Eps Cop. Y/Y
Eps Net Y/Y
Free Cash Flow Y/Y
Cash Flow Y/Y
Capex Y/Y
Gross Margin
EBITDA Margin
Operating Margin
Net Margin
Pre-Tax Margin
Free Cash Flow Margin
Cash Flow Margin
P/E Ratio TTM
P/S Ratio TTM
P/CF Ratio TTM
P/FCF Ratio TTM
Price to Book MRQ
Price to Tangible Book
ROA Quarterly
ROI Quarterly
ROE Quarterly
Quick Ratio
Quick Ratio TTM
Working Capital
Working Capital TTM
Long Term Debt to Equity
Long Term Debt to Equity TTM
Debt to Equity
Debt to Equity TTM
Leverage Ratio
Leverage Ratio TTM
Tangible Leverage Ratio
Interest Coverage
Debt Coverage
Working Capital Per Revenue
Sales per Employee
Income per Employee
Inventory to Sales
Inventory Turnover
Asset Turnover
Receivables Turnover
Dividend Growth
Dividend Payout
Cumulative Payout
Annual Dividend Payout
Revenue Annual Growth
Operating Income Annual Growth
Income from Continued Operations Annual Growth
Net Income Annual Growth
Eps Continued Operations Annual Growth
Eps Net Annual Growth
Free Cash Flow Annual Growth
Cash Flow Annual Growth
Capex Annual Growth
ARTH Annual Income from Cont. Operations Growth
2023
2022
2021
2020
2019
Y / Y Annual Income from Cont. Operations Change
-
-
-
-
-
Annual Income from Cont. Operations (in millions $)
$-6.98
$-5.28
$-6.24
$-4.69
$-4.55
ARTH Company Profile
>>
Back to ARTH Fundamentals at a Glance
>>
Back to ARTH Growth Comparisons
Annual Income from Cont. Operations Growth Comment
Arch Therapeutics Inc
realized loss from Cont. Operations.
Arch Therapeutics Inc Annual Income Statement
You need to upgrade your Flash Player
Companies with similar 2023 Annual Income from Cont. Operations within Healthcare Sector
Y/Y Income from Continued Operations Growth %
2023 Annual Income from Cont. Operations
Viatris Inc
-97.37 %
$ 54.700 millions
Kiniksa Pharmaceuticals ltd
-92.32 %
$ 14.084 millions
Integra Lifesciences Holdings Corp
-62.48 %
$ 67.741 millions
Msa Safety Incorporated
-67.39 %
$ 58.583 millions
Molecular Partners Ag